Officers

Emile Nuwaysir Headshot
Chair

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics
Usman Azam Headshot
Vice-Chair

Usman Azam

President & Chief Executive Officer,
Tmunity Therapeutics
Amy Butler Headshot
Secretary

Amy Butler

President, Biosciences,
Thermo Fisher Scientific
Devyn Smith Headshot
Treasurer

Devyn Smith

Chief Executive Officer,
Arbor Biotechnologies

Board of Directors

Usman Azam

President & Chief Executive Officer,
Tmunity Therapeutics

Ron Bartek

Co-Founder and President,
Friedreich's Ataxia Research Alliance

Mark Battaglini

SVP, Global Corporate Affairs & US Government Payer,
bluebird bio

Amy Butler

President, Biosciences,
Thermo Fisher Scientific

Bradley Campbell

President and Chief Operating Officer,
Amicus Therapeutics

Maria Fardis

CEO,
Iovance Biotherapeutics

Miguel Forte

Chief Executive Officer,
Bone Therapeutics

Jonathan Garen

Chief Business Officer,
uniQure

Bobby Gaspar

CEO,
Orchard Therapeutics

Jerry Keybl

Senior Director, Cell & Gene Therapy,
MilliporeSigma

Brett Kopelan

Executive Director,
Debra of America

Ann Lee

Senior Vice President and Head of Cell Therapy Development & Operations,
Bristol-Myers Squibb

Dave Lennon

President,
Novartis Gene Therapies

Bruce Levine

Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania

John Maslowski

Chief Executive Officer,
Castle Creek Pharmaceuticals

Claudia Mitchell

Senior VP, Product and Portfolio Strategy,
Astellas Pharma

Adora Ndu

Group Vice President, Worldwide Research & Development Strategy, Scientific Collaborations and Policy,
BioMarin

Susan Nichols

Former CEO,
Falcon Therapeutics

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics

Karah Parschauer

General Counsel and Executive Vice President,
Ultragenyx

Matt Patterson (ex-officio)

Director,
Vor BioPharma

Louise Rodino-Klapac

Executive Vice President, Chief Scientific Officer,
Sarepta Therapeutics

Jeff Ross

Chief Executive Officer,
Miromatrix Medical

R.A. Session

President, Founder & CEO,
Taysha Therapeutics

Curran Simpson

Senior Vice President, Product Development, and Chief Technical Officer,
REGENXBIO

Sanjaya Singh

Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development

Bob Smith

Senior Vice President, Global Gene Therapy Business,
Pfizer

Devyn Smith

Chief Executive Officer,
Arbor Biotechnologies

Joe Tarnowski

Senior Vice President, Cell and Gene Therapy Platform,
GlaxoSmithKline

Arthur Tzianabos

President and Chief Executive Officer,
Homology Medicines

Christopher Vann

Chief Operating Officer,
Autolus Therapeutics

Jason Wertheim

Edward G. Elcock Professor of Surgical Research and Associate Professor, Division of Transplantation,
Northwestern University

Kristin Yarema

CCO,
Atara Bio

Executive Committee

Usman Azam

President & Chief Executive Officer,
Tmunity Therapeutics

Amy Butler

President, Biosciences,
Thermo Fisher Scientific

Miguel Forte

Chief Executive Officer,
Bone Therapeutics

Claudia Mitchell

Senior VP, Product and Portfolio Strategy,
Astellas Pharma

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics

Bob Smith

Senior Vice President, Global Gene Therapy Business,
Pfizer

Devyn Smith

Chief Executive Officer,
Arbor Biotechnologies

Arthur Tzianabos

President and Chief Executive Officer,
Homology Medicines

Christopher Vann

Chief Operating Officer,
Autolus Therapeutics